“Experimental and Computational Evidence for Xanthatin As a Multi-Target Anti-Cancer Agent in Ovarian Cancer”. 2025. Bangladesh Journal of Pharmacology 20 (4): 158-68. https://doi.org/10.3329/bjp.v20i4.84621.